See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Aurelien Delluc

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	42058833	0	Mai V, Martens ESL, Righini M, et al. Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism. Res Pract Thromb Haemost. 2026 Mar 25;10(3):103442. doi: 10.1016/j.rpth.2026.103442. eCollection 2026 Mar.
	41924909	0	Fotiou D, Antic D, Delluc A, et al. Diagnostic and therapeutic challenges in rare hematologic entities: monoclonal gammopathy of thrombotic and bleeding significance. Haematologica. 2026 Apr 2. doi: 10.3324/haematol.2025.300196.
	41843780	0	Paquette ML, Miranda S Dr, Xu Y, et al. Perioperative Management of Antithrombotic Therapy in Patients with Thrombotic Antiphospholipid Syndrome. Blood Adv. 2026 Mar 17:bloodadvances.2026019610. doi: 10.1182/bloodadvances.2026019610.
	41791657	0	Kou R, Mallick R, Brown C, et al. Anticoagulation management and outcomes in patients with cancer-associated small venous thromboembolism: A retrospective cohort study. J Thromb Haemost. 2026 Mar 4:S1538-7836(26)00122-4. doi: 10.1016/j.jtha.2026.02.006.
	41740417	0	Girardi L, Delluc A. Rebuttal to correspondence on "Diagnostic accuracy meta-analysis of portal vein thrombosis imaging". Thromb Res. 2026 Feb 19;259:109628. doi: 10.1016/j.thromres.2026.109628.
	41588795	0	Simard C, Le Gal G, Lazo-Langner A, et al. Association Between Bariatric Surgery and the Long-Term Risk for Venous Thromboembolism: A Population-Based Matched Cohort Study. Am J Hematol. 2026 Jan 26. doi: 10.1002/ajh.70186.
	41543789	0	Purcell A, Ni Ainle F, Hunt BJ, et al. Venous thromboembolism prophylaxis in adults hospitalised for psychiatric illness: an evidence-based clinical practice guideline developed using GRADE. Int J Clin Pharm. 2026 Jan 16. doi: 10.1007/s11096-025-02072-1.
	41397561	0	Simard C, Siegal DM, Nguyen L, et al. Comparative Analysis of Radiation Exposure from CT Scan and VQ Scan in the Diagnosis of Pulmonary Embolism: An Early-Onset Cancer Risk Assessment. J Thromb Haemost. 2025 Dec 13:S1538-7836(25)00894-3. doi: 10.1016/j.jtha.2025.12.005.
	41380653	0	Girardi L, Zarka F, Pradier M, et al. Diagnostic performance of ultrasound, computed tomography and magnetic resonance imaging in portal vein thrombosis: A systematic review with meta-analysis. Thromb Res. 2025 Dec 5;257:109560. doi: 10.1016/j.thromres.2025.109560.
	41211763	0	Wang TF, Yeo E, Gross PL, et al. A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study. Am J Hematol. 2025 Nov 10. doi: 10.1002/ajh.70127.
	41065579	0	Delluc A, Carrier M, Lauw M, et al. Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey. Blood Coagul Fibrinolysis. 2025 Oct 6. doi: 10.1097/MBC.0000000000001388.
	41031136	0	Guman NAM, Kraaijpoel N, Mulder FI, et al. Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study. Res Pract Thromb Haemost. 2025 Aug 19;9(6):103018. doi: 10.1016/j.rpth.2025.103018. eCollection 2025 Aug.
	40579365	0	Khan F, Tritschler T, Marx CE, et al. Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis. Eur Heart J. 2025 Jun 22:ehaf453. doi: 10.1093/eurheartj/ehaf453.
	40578691	0	Mai V, Martens ESL, Righini M, et al. Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. J Thromb Haemost. 2025 Jun 25:S1538-7836(25)00408-8. doi: 10.1016/j.jtha.2025.06.019.
	40288681	0	Siegal DM, Arsenault MP, Abdulrehman J, et al. Venous Thromboembolism after Hospitalization for COVID-19: Venous Thrombosis Virtual Surveillance in COVID (VVIRTUOSO) Study. J Thromb Haemost. 2025 Apr 25:S1538-7836(25)00268-5. doi: 10.1016/j.jtha.2025.04.018.
	39603673	0	Delluc A, Pradier M, Siegal DM, et al. Outpatient Management of Cancer-Associated Pulmonary Embolism: A Systematic Review and Meta-Analysis. Eur Respir J. 2024 Nov 27:2401596. doi: 10.1183/13993003.01596-2024.
	39442625	0	Anuku D, Carrier M, Le Gal G, et al. Impact of limited language proficiency on participation in venous thromboembolism research: A retrospective analysis. J Thromb Haemost. 2024 Oct 21:S1538-7836(24)00562-2. doi: 10.1016/j.jtha.2024.09.014.
	38875846	0	Brown C, Tokessy L, Delluc A, et al. Risk of developing post thrombotic syndrome after deep vein thrombosis with different anticoagulant regimens: A systematic review and pooled analysis. Thromb Res. 2024 Jun 3;240:109057. doi: 10.1016/j.thromres.2024.109057.
	38866248	0	Guman NAM, Becking AL, Weijers SS, et al. Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study. J Thromb Haemost. 2024 Jun 10:S1538-7836(24)00323-4. doi: 10.1016/j.jtha.2024.05.031.
	38065528	0	Wang TF, Kou R, Carrier M, et al. Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: A systematic review and meta-analysis. J Thromb Haemost. 2023 Dec 6:S1538-7836(23)00855-3. doi: 10.1016/j.jtha.2023.11.017.
	37984078	0	Wang TF, Delluc A, Cervi A, et al. A survey of clinician perspectives on the management of catheter-related upper extremity deep vein thrombosis in patients with cancer. Thromb Res. 2023 Nov 16;233:10-13. doi: 10.1016/j.thromres.2023.11.012.
	37907305	0	Makedonov I, Kahn S, Abdulrehman J, et al. TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol. BMJ Open. 2023 Oct 31;13(10):e064715. doi: 10.1136/bmjopen-2022-064715.
	37857226	0	Wang TF, Hill M, Mallick R, et al. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies. Thromb Res. 2023 Oct 11;231:128-134. doi: 10.1016/j.thromres.2023.10.004.
	37640450	0	Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023 Aug 28:ard-2023-224609. doi: 10.1136/ard-2023-224609.
	37635643	0	Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023 Aug 28. doi: 10.1002/art.42624.
	37517478	0	Marx CE, Schenker C, Xu Y, et al. Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort. J Thromb Haemost. 2023 Jul 28:S1538-7836(23)00577-9. doi: 10.1016/j.jtha.2023.07.015.
	37340812	0	Wang TF, Grubic N, Carrier M, et al. Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty. Am J Hematol. 2023 Jun 21. doi: 10.1002/ajh.26994.
	37308131	0	Gaugler JO, Righini M, Robert-Ebadi H, et al. Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism. Thromb Haemost. 2023 Jun 12. doi: 10.1055/s-0043-57018.
	37301116	0	Brown C, Brandt W, Wang TF, et al. Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis. Thromb Res. 2023 Jun 4;228:81-84. doi: 10.1016/j.thromres.2023.05.027.
	37196605	0	Wang TF, Carrier M, Carney BJ, et al. Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: A systematic review and meta-analysis. Thromb Res. 2023 May 11;227:8-16. doi: 10.1016/j.thromres.2023.05.012.
	37121015	0	Potere N, Di Nisio M, Porreca E, et al. Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial. Thromb Res. 2023 Apr 26;226:82-85. doi: 10.1016/j.thromres.2023.04.015.
	36841648	0	Mulder FI, Kraaijpoel N, Carrier M, et al. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study. J Thromb Haemost. 2023 Jan 11:S1538-7836(23)00031-4. doi: 10.1016/j.jtha.2023.01.003.
	36809776	0	Pradier M, Rodger MA, Ghanima W, et al. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study. Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3388.
	36696186	0	Caiano LM, Drury T, Zahrai A, et al. Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)18246-2. doi: 10.1016/j.jtha.2022.12.008.
	36268462	0	Attard LM, Gatt A, Bertoletti L, et al. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis. Vasc Health Risk Manag. 2022 Oct 13;18:793-807. doi: 10.2147/VHRM.S271411. eCollection 2022.
	36210560	0	Delluc A, Robin P. (18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know? Thromb Res. 2022 May;213 Suppl 1:S42-S45. doi: 10.1016/j.thromres.2022.01.018. Epub 2022 May 26.
	35439303	0	Ageno W, Beyer-Westendorf J, Contino L, et al. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood Adv. 2022 Apr 19. pii: 484971. doi: 10.1182/bloodadvances.2022007397.
	35344784	0	Delluc A, Ghanima W, Kovacs MJ, et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022 Mar 19;213:119-124. doi: 10.1016/j.thromres.2022.03.014.
	35021257	0	Ng S, Rodger MA, Ghanima W, et al. External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1313.
	34852380	0	Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263.
	34845714	0	Delluc A, Wang TF. How to treat incidental pulmonary embolism in cancer patients? Recent advances. Kardiol Pol. 2021 Nov 30. pii: VM/OJS/J/87173. doi: 10.33963/KP.a2021.0164.
	34795036	0	Caiano L, Sharkey R, Rodger MA, et al. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism. Results from the REVERSE study. Eur Respir J. 2021 Nov 18. pii: 13993003.01801-2021. doi: 10.1183/13993003.01801-2021.
	34742140	0	Nayak AL, Zahrai A, Mallick R, et al. Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial. Thromb Res. 2021 Oct 26;208:79-82. doi: 10.1016/j.thromres.2021.10.018.
	34715510	0	Li A, Brandt W, Brown C, et al. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis. Thromb Res. 2021 Oct 24;208:58-65. doi: 10.1016/j.thromres.2021.10.012.
	34564938	0	Delluc A, Ghanima W, Kovacs MJ, et al. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility. J Thromb Haemost. 2021 Sep 26. doi: 10.1111/jth.15537.
	34399433	0	Wang TF, Carrier M, Fournier K, et al. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis. Thromb Haemost. 2021 Aug 16. doi: 10.1055/a-1588-9155.
	34255928	0	Tritschler T, Salvatore SP, Kahn SR, et al. ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. J Thromb Haemost. 2021 Oct;19(10):2514-2521. doi: 10.1111/jth.15458. Epub 2021 Aug 1.
	34161655	0	Caiano L, Carrier M, Marshall A, et al. Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2468-2479. doi: 10.1111/jth.15435. Epub 2021 Jul 12.
	33190023	0	Roberge G, Delluc A. Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer. Thromb Res. 2021 Jan;197:77-83. doi: 10.1016/j.thromres.2020.10.033. Epub 2020 Nov 6.
	32654308	0	AlBader M, Le Gal G, Rodger MA, et al. Yield of ultrasonography in patients with or without post-thrombotic syndrome for diagnosis of suspected recurrent ipsilateral deep vein thrombosis. J Thromb Haemost. 2020 Oct;18(10):2654-2657. doi: 10.1111/jth.14996. Epub 2020 Aug 28.
	32416310	0	Delluc A, Lacut K, Rodger MA. Arterial and venous thrombosis: What's the link? A narrative review. Thromb Res. 2020 Jul;191:97-102. doi: 10.1016/j.thromres.2020.04.035. Epub 2020 Apr 27.
	32395827	0	Wang TF, Delluc A. Thromboprophylaxis in patients with multiple myeloma. Br J Haematol. 2020 Aug;190(4):493-494. doi: 10.1111/bjh.16731. Epub 2020 May 12.
	31899848	0	Galanaud JP, Righini M, Le Collen L, et al. Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study. J Thromb Haemost. 2020 Apr;18(4):857-864. doi: 10.1111/jth.14728. Epub 2020 Feb 11.
	31872492	0	Miranda S, Park J, Le Gal G, et al. Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism. J Thromb Haemost. 2020 Apr;18(4):926-930. doi: 10.1111/jth.14720. Epub 2020 Feb 17.
	31582557	0	Stephen MS, Castellucci L, Carrier M, et al. Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism. Haematologica. 2020 Jun;105(6):e307-e309. doi: 10.3324/haematol.2019.232884. Epub 2019 Oct 3.
	31279158	0	Rodger MA, Miranda S, Delluc A, et al. Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next? Thromb Res. 2019 Aug;180:105-109. doi: 10.1016/j.thromres.2019.06.017. Epub 2019 Jun 26.
	31273089	0	Delluc A, Miranda S, Exter PD, et al. Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis. Haematologica. 2020 May;105(5):1436-1442. doi: 10.3324/haematol.2019.222828. Epub 2019 Jul 4.
	31207027	0	Delluc A, Wang TF, Yap ES, et al. Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH. J Thromb Haemost. 2019 Aug;17(8):1247-1252. doi: 10.1111/jth.14478. Epub 2019 Jun 17.
	30685873	0	Rezig S, Mao RL, Couturaud F, et al. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event. Thromb Haemost. 2019 Mar;119(3):490-495. doi: 10.1055/s-0039-1677745. Epub 2019 Jan 27.
	30268858	0	Robin P, Otten HM, Delluc A, et al. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism. Thromb Res. 2018 Nov;171:92-96. doi: 10.1016/j.thromres.2018.09.055. Epub 2018 Sep 23.
	30076179	0	Delluc A, Le Mao R, Tromeur C, et al. Incidence of upper-extremity deep vein thrombosis in western France: a community-based study. Haematologica. 2019 Jan;104(1):e29-e31. doi: 10.3324/haematol.2018.194951. Epub 2018 Aug 3.
	29880445	0	Delluc A, Clemons M. Poor outcomes after venous thromboembolism in cancer patients: It's time to change practice. Thromb Res. 2018 Nov;171:177-178. doi: 10.1016/j.thromres.2018.06.003. Epub 2018 Jun 2.
	29787944	0	Delluc A, Lacut K, Pan-Petesch B, et al. Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms. Thromb Res. 2018 Jul;167:57-59. doi: 10.1016/j.thromres.2018.05.014. Epub 2018 May 16.
	29775482	0	Heraudeau A, Delluc A, Le Henaff M, et al. Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study. PLoS One. 2018 May 18;13(5):e0194973. doi: 10.1371/journal.pone.0194973. eCollection 2018.
	29522910	0	Delluc A, Ianotto JC, Tromeur C, et al. Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study. Thromb Res. 2018 Apr;164:79-84. doi: 10.1016/j.thromres.2018.02.151. Epub 2018 Mar 2.
	29402471	0	Bertoletti L, Benhamou Y, Bejot Y, et al. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Rev. 2018 Jul;32(4):272-279. doi: 10.1016/j.blre.2018.01.002. Epub 2018 Apr 20.
	29164292	0	Mahe K, Delluc A, Chauveau A, et al. Incidence and impact of atrial arrhythmias on thrombotic events in MPNs. Ann Hematol. 2018 Jan;97(1):101-107. doi: 10.1007/s00277-017-3164-x. Epub 2017 Nov 21.
	29046258	0	De Moreuil C, Le Mao R, Tromeur C, et al. Association between statin exposure and venous thromboembolism risk in cancer patients. Data from the EDITH case-control study. Eur J Intern Med. 2017 Dec;46:e42-e44. doi: 10.1016/j.ejim.2017.10.008. Epub 2017 Oct 16.
	28988597	0	Dillinger JG, Aleil B, Cheggour S, et al. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Arch Cardiovasc Dis. 2018 Feb;111(2):85-94. doi: 10.1016/j.acvd.2017.04.008. Epub 2017 Oct 2.
	28751412	0	Le Mao R, Tromeur C, Bazire A, et al. Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study. Eur Respir J. 2017 Jul 27;50(1). pii: 50/1/1700094. doi: 10.1183/13993003.00094-2017. Print 2017 Jul.
	28647342	0	Hemon F, Fouchard F, Tromeur C, et al. Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study. Eur J Intern Med. 2017 Oct;44:39-43. doi: 10.1016/j.ejim.2017.05.029. Epub 2017 Jun 22.
	28623609	0	Ianotto JC, Couturier MA, Galinat H, et al. Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms. Int J Hematol. 2017 Oct;106(4):517-521. doi: 10.1007/s12185-017-2282-5. Epub 2017 Jun 16.
	27766390	0	Ianotto JC, Chauveau A, Mottier D, et al. JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort. Ann Hematol. 2017 Mar;96(3):383-386. doi: 10.1007/s00277-016-2853-1. Epub 2016 Oct 20.
	27592403	0	Astruc N, Ianotto JC, Metges JP, et al. External validation of the modified Ottawa score for risk stratification of recurrent cancer-associated thrombosis. Eur J Intern Med. 2016 Dec;36:e11-e12. doi: 10.1016/j.ejim.2016.08.001. Epub 2016 Aug 31.
	27465905	0	Delluc A, Tromeur C, Le Ven F, et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. Thromb Haemost. 2016 Oct 28;116(5):967-974. doi: 10.1160/TH16-03-0205. Epub 2016 Jul 28.
	26672686	0	Robin P, Le Roux PY, Planquette B, et al. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial. Lancet Oncol. 2016 Feb;17(2):193-199. doi: 10.1016/S1470-2045(15)00480-5. Epub 2015 Dec 8.
	26603493	0	Delluc A, Carrier M. Catheter-related thrombosis: Unresolved issues. Thromb Res. 2015 Dec;136(6):1055-6. doi: 10.1016/j.thromres.2015.10.027. Epub 2015 Oct 19.
	26538494	0	Andro M, Delluc A, Moineau MP, et al. Serum levels of 25(OH)D are not associated with venous thromboembolism in the elderly population. A case-control study. Thromb Haemost. 2016 Jan;115(1):169-75. doi: 10.1160/TH15-02-0148. Epub 2015 Nov 5.
	26452982	0	Le Moigne E, Tromeur C, Delluc A, et al. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study. Haematologica. 2016 Jan;101(1):e12-4. doi: 10.3324/haematol.2015.134882. Epub 2015 Oct 9.
	26290216	0	Ianotto JC, Chauveau A, Luque Paz D, et al. Absence of CALR mutation among a cohort of 394 unselected patients with a first episode of unprovoked venous thromboembolism. Thromb Haemost. 2016 Jan;115(1):225-6. doi: 10.1160/TH15-02-0134. Epub 2015 Aug 20.
	25491940	0	Delluc A, Le Gal G, Scarvelis D, et al. Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients. Thromb Res. 2015 Feb;135(2):298-302. doi: 10.1016/j.thromres.2014.11.020. Epub 2014 Dec 2.
	25455997	0	Le Roux PY, Robin P, Delluc A, et al. Performance of 18F fluoro-2-desoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism. Thromb Res. 2015 Jan;135(1):31-5. doi: 10.1016/j.thromres.2014.10.008. Epub 2014 Oct 20.